BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 22575886)

  • 1. Adult-onset PYY overexpression in mice reduces food intake and increases lipogenic capacity.
    Shi YC; Hämmerle CM; Lee IC; Turner N; Nguyen AD; Riepler SJ; Lin S; Sainsbury A; Herzog H; Zhang L
    Neuropeptides; 2012 Aug; 46(4):173-82. PubMed ID: 22575886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PYY transgenic mice are protected against diet-induced and genetic obesity.
    Boey D; Lin S; Enriquez RF; Lee NJ; Slack K; Couzens M; Baldock PA; Herzog H; Sainsbury A
    Neuropeptides; 2008 Feb; 42(1):19-30. PubMed ID: 18164057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NPY modulates PYY function in the regulation of energy balance and glucose homeostasis.
    Zhang L; Nguyen AD; Lee IC; Yulyaningsih E; Riepler SJ; Stehrer B; Enriquez RF; Lin S; Shi YC; Baldock PA; Sainsbury A; Herzog H
    Diabetes Obes Metab; 2012 Aug; 14(8):727-36. PubMed ID: 22369253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of genetically obese mice with the iminosugar N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin reduces body weight by decreasing food intake and increasing fat oxidation.
    Langeveld M; van den Berg SA; Bijl N; Bijland S; van Roomen CP; Houben-Weerts JH; Ottenhoff R; Houten SM; van Dijk KW; Romijn JA; Groen AK; Aerts JM; Voshol PJ
    Metabolism; 2012 Jan; 61(1):99-107. PubMed ID: 21816446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
    Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
    J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide YY directly inhibits ghrelin-activated neurons of the arcuate nucleus and reverses fasting-induced c-Fos expression.
    Riediger T; Bothe C; Becskei C; Lutz TA
    Neuroendocrinology; 2004; 79(6):317-26. PubMed ID: 15256809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ghrelin and PYY in the regulation of energy balance and metabolism: lessons from mouse mutants.
    Kirchner H; Tong J; Tschöp MH; Pfluger PT
    Am J Physiol Endocrinol Metab; 2010 May; 298(5):E909-19. PubMed ID: 20179246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological evidence for the involvement of peptide YY in the regulation of energy homeostasis in humans.
    Guo Y; Ma L; Enriori PJ; Koska J; Franks PW; Brookshire T; Cowley MA; Salbe AD; Delparigi A; Tataranni PA
    Obesity (Silver Spring); 2006 Sep; 14(9):1562-70. PubMed ID: 17030967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of food intake in obese subjects by peptide YY3-36.
    Batterham RL; Cohen MA; Ellis SM; Le Roux CW; Withers DJ; Frost GS; Ghatei MA; Bloom SR
    N Engl J Med; 2003 Sep; 349(10):941-8. PubMed ID: 12954742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic PYY3-36 treatment promotes fat oxidation and ameliorates insulin resistance in C57BL6 mice.
    van den Hoek AM; Heijboer AC; Voshol PJ; Havekes LM; Romijn JA; Corssmit EP; Pijl H
    Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E238-45. PubMed ID: 16940471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citrate diminishes hypothalamic acetyl-CoA carboxylase phosphorylation and modulates satiety signals and hepatic mechanisms involved in glucose homeostasis in rats.
    Cesquini M; Stoppa GR; Prada PO; Torsoni AS; Romanatto T; Souza A; Saad MJ; Velloso LA; Torsoni MA
    Life Sci; 2008 Jun; 82(25-26):1262-71. PubMed ID: 18534630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
    Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A PYY Q62P variant linked to human obesity.
    Ahituv N; Kavaslar N; Schackwitz W; Ustaszewska A; Collier JM; Hébert S; Doelle H; Dent R; Pennacchio LA; McPherson R
    Hum Mol Genet; 2006 Feb; 15(3):387-91. PubMed ID: 16368708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective FFA2 Agonism Appears to Act via Intestinal PYY to Reduce Transit and Food Intake but Does Not Improve Glucose Tolerance in Mouse Models.
    Forbes S; Stafford S; Coope G; Heffron H; Real K; Newman R; Davenport R; Barnes M; Grosse J; Cox H
    Diabetes; 2015 Nov; 64(11):3763-71. PubMed ID: 26239054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of restraint and disinhibition on PYY plasma levels and subjective feelings of appetite.
    Martins C; Robertson MD; Morgan LM
    Appetite; 2010 Oct; 55(2):208-13. PubMed ID: 20541573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total peptide YY is a correlate of postprandial energy expenditure but not of appetite or energy intake in healthy women.
    Doucet E; Laviolette M; Imbeault P; Strychar I; Rabasa-Lhoret R; Prud'homme D
    Metabolism; 2008 Oct; 57(10):1458-64. PubMed ID: 18803953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of food intake and energy expenditure by hypothalamic malonyl-CoA.
    Lane MD; Wolfgang M; Cha SH; Dai Y
    Int J Obes (Lond); 2008 Sep; 32 Suppl 4():S49-54. PubMed ID: 18719599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice.
    Moriya R; Mashiko S; Ishihara A; Takahashi T; Murai T; Ito J; Mitobe Y; Oda Z; Iwaasa H; Takehiro F; Kanatani A
    Peptides; 2009 Jul; 30(7):1318-22. PubMed ID: 19394383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide YY regulates bone turnover in rodents.
    Wortley KE; Garcia K; Okamoto H; Thabet K; Anderson KD; Shen V; Herman JP; Valenzuela D; Yancopoulos GD; Tschöp MH; Murphy A; Sleeman MW
    Gastroenterology; 2007 Nov; 133(5):1534-43. PubMed ID: 17920065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide YY levels are elevated after gastric bypass surgery.
    Chan JL; Mun EC; Stoyneva V; Mantzoros CS; Goldfine AB
    Obesity (Silver Spring); 2006 Feb; 14(2):194-8. PubMed ID: 16571843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.